SNT ASX · Health Care

Syntara Ltd

Announcements, last 12 months: 83
Price sensitive, last 12 months: 20
Followed on InvestorPA: Some (top 20% of companies)

Upcoming events

Thu 19 Nov 2026, 9:00 AM AEDT

2026 Annual General Meeting of Syntara Limited

Latest announcements

Released	Headline	Actions
20 Oct 2026, 11:47 AM	Notice of Annual General Meeting/Proxy Form
13 Oct 2026, 8:43 AM	Investor Presentation Canaccord Drug & Device Conference
7 Oct 2026, 9:32 AM	Further significant results from SNT-4728 iRBD Phase 2 trial Price sensitive	AI summary
5 Oct 2026, 2:24 PM	Notification regarding unquoted securities - SNT
5 Oct 2026, 2:21 PM	Notification regarding unquoted securities - SNT
1 Oct 2026, 9:49 AM	Syntara expands SNT-9465 skin scarring study Price sensitive	AI summary
21 Sep 2026, 8:45 AM	Syntara receives A$4.7m R&D Tax Incentive
15 Sep 2026, 10:01 AM	Application for quotation of securities - SNT
15 Sep 2026, 9:58 AM	Notification of 2026 AGM Date
27 Aug 2026, 2:50 PM	Appendix 4G and Corporate Governance Statement

Sign in to see all SNT announcements.

Guidance history

1 Oct 2026	Top-line results expected in Q1 2027
10 Jun 2026	Total funds raised: $8.84M; cash runway to Q3 2027
30 Apr 2026	The company expects five clinical data readouts during calendar year 2026 across its pipeline.

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow SNT to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.